Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Gains from Sales and Divestitures: 2018-2025

Historic Gains from Sales and Divestitures for Verastem (VSTM) over the last 7 years, with Sep 2025 value amounting to $642,000.

  • Verastem's Gains from Sales and Divestitures rose 716.20% to $642,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $642,000, marking a year-over-year increase of 716.20%. This contributed to the annual value of $468,581 for FY2024, which is N/A change from last year.
  • Verastem's Gains from Sales and Divestitures amounted to $642,000 in Q3 2025, which was up 8.50% from $591,731 recorded in Q2 2025.
  • In the past 5 years, Verastem's Gains from Sales and Divestitures registered a high of $5.3 million during Q4 2022, and its lowest value of $14,279 during Q1 2024.
  • Over the past 3 years, Verastem's median Gains from Sales and Divestitures value was $96,500 (recorded in 2024), while the average stood at $225,592.
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first tumbled by 93.76% in 2024, then skyrocketed by 1,665.78% in 2025.
  • Verastem's Gains from Sales and Divestitures (Quarterly) stood at $5.0 million in 2021, then grew by 5.44% to $5.3 million in 2022, then slumped by 88.13% to $49,815 in 2023, then skyrocketed by 57.90% to $468,581 in 2024, then spiked by 716.20% to $642,000 in 2025.
  • Its Gains from Sales and Divestitures stands at $642,000 for Q3 2025, versus $591,731 for Q2 2025 and $114,342 for Q1 2025.